These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 381086)

  • 21. [Bromhexine (Bisolvon). An evaluation from the literature].
    Kampmann JP
    Ugeskr Laeger; 1974 Jul; 136(31):1757-9. PubMed ID: 4605541
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of Paxirasol aerosol on the clinical condition and objective functional respiratory parameters of obstructive respiratory tract disease patients.
    Mészáros L; Molnár B; Beke M
    Ther Hung; 1991; 39(3):128-32. PubMed ID: 1818426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Flegamin - Polish equivalent of bisolvon. Results of clinical studies].
    Owsiński J; Ciezarek M; Kamińska M; Lukasiewicz W; Maternowska W; Walaszek K; Nikodemowicz E
    Pol Tyg Lek; 1980 Mar; 35(12):449-51. PubMed ID: 7383936
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of guacetisal in chronic obstructive bronchopneumopathy. Controlled clinical study].
    Cerqua R; Trovello C; Infante G; Ricciardi S
    Minerva Med; 1981 Feb; 72(7):355-62. PubMed ID: 7017485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental studies on bronchial secretion. Therapeutical aspects of pathological bronchial secretion.
    Simonsson BG
    Scand J Respir Dis Suppl; 1974; 90():1-89. PubMed ID: 4618374
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pluridirectional treatment of chronic, obstructive bronchopneumopathy with rectal administration of a new drug combination].
    Nappi L; Taglialatela G; Verde F
    Clin Ter; 1972 Dec; 63(6):577-86. PubMed ID: 4570863
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of the simultaneous aerosol administration of fenoterol and 2(alpha-thenoylthio)propionylglycine].
    Ardizzi A; Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Scappaticci E
    Minerva Med; 1986 Oct; 77(39):1823-6. PubMed ID: 3534632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of bronvho-pulmonary obstructive disease states.
    Lipman WH
    Med Times; 1967 Dec; 95(12):1295-302. PubMed ID: 6081119
    [No Abstract]   [Full Text] [Related]  

  • 29. [Documentation on bromhexine: What is the truth?].
    Mossberg B; Nilsson BS
    Lakartidningen; 1978 Mar; 75(9):765-7. PubMed ID: 628271
    [No Abstract]   [Full Text] [Related]  

  • 30. Physiopathological rationale and clinical aims of the use of a combination of cefuroxime and N-acetylcysteine in pneumology.
    Girbino G; Giacobbe G; Arsena A; Ferrara F
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):166-72. PubMed ID: 3997303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mucolytic effects of acetylcysteine compared with bromhexine and a placebo in patients with chronic bronchitis].
    Heinig JH; Pedersen B; Andersen I; Dalgaard CE; Rasmussen O; Weeke ER; Enk B
    Ugeskr Laeger; 1985 Nov; 147(46):3694-7. PubMed ID: 3907080
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease].
    Dorow P; Weiss T; Felix R; Schmutzler H
    Arzneimittelforschung; 1987 Dec; 37(12):1378-81. PubMed ID: 3449066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Progesterone treatment of the obstructive chronic bronchopneumopathy syndrome].
    Villano D
    Bronchopneumologie; 1978; 28(4):328-33. PubMed ID: 756800
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: "Bisolvon" in chronic respiratory disease.
    Watson EW
    Med J Aust; 1974 Feb; 1(5):152. PubMed ID: 4818003
    [No Abstract]   [Full Text] [Related]  

  • 35. Double-blind crossover trial of bromhexine (Bisolvon) in the treatment of chronic bronchitis.
    Armstrong ML
    Med J Aust; 1976 Apr; 1(17):612,614-5,617. PubMed ID: 778563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and clinical evaluation of feprazonebromhexine association in bronchopulmonary diseases.
    Del Bono N; Quartieri F; Renda B; Sconosciuto F; Vibelli C
    Panminerva Med; 1978; 20(2):117-22. PubMed ID: 360150
    [No Abstract]   [Full Text] [Related]  

  • 37. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of a feprazone-bromhexine combination in acute and chronic bronchopneumopathies].
    Alessandrini A; Bianchi RM; Geromino A; Negri L
    Clin Ter; 1983 Nov; 107(3):185-91. PubMed ID: 6362963
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
    Germouty J; Jirou-Najou JL
    Respiration; 1987; 51 Suppl 1():37-41. PubMed ID: 3299566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics, drug availability and clinical pharmacology of bromhexine].
    Renovanz HD
    Wien Klin Wochenschr; 1973 Sep; 123(37):Suppl 7:1-8. PubMed ID: 4201509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.